Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Tetracaine Hydrochloride

Tetracaine Hydrochloride

136-47-0

DISCOVER
3E,8Z-Tetradecadienyl Acetate

3E,8Z-Tetradecadienyl Acetate

163041-87-0

DISCOVER
UBIDECARENONE CRS (70 MG)

UBIDECARENONE CRS (70 MG)

303-98-0

DISCOVER
UBIDECARENONE FOR SYSTEM SUITABILITY CRS (1 MG)

UBIDECARENONE FOR SYSTEM SUITABILITY CRS (1 MG)

303-98-0

DISCOVER
UBIDECARENONE IMPURITY D CRS (5 MG)

UBIDECARENONE IMPURITY D CRS (5 MG)

303-97-9

DISCOVER
URACIL ARABINOSIDE CRS (60 MG)

URACIL ARABINOSIDE CRS (60 MG)

NA

DISCOVER
Ursodeoxycholic Acid 13C24

Ursodeoxycholic Acid 13C24

63296-46-8

DISCOVER
UREA CRS (100 MG)

UREA CRS (100 MG)

57-13-6

DISCOVER
URSODEOXYCHOLIC ACID CRS (90 MG)

URSODEOXYCHOLIC ACID CRS (90 MG)

128-13-2

DISCOVER
VALINE CRS (50 MG)

VALINE CRS (50 MG)

72-18-4

DISCOVER
VALPROIC ACID CRS (100 MG)

VALPROIC ACID CRS (100 MG)

99-66-1

DISCOVER
VANCOMYCIN HYDROCHLORIDE CRS (100 MG)

VANCOMYCIN HYDROCHLORIDE CRS (100 MG)

1404-93-9

DISCOVER